Vaccine News and Research

Latest Vaccine News and Research

How comorbidities impact antibody response to COVID vaccination

Scientists from the United States have recently investigated the impact of pre-existing health conditions on the robustness and durability of immune responses induced by mRNA-based coronavirus disease 2019 (COVID-19) vaccination.

6 Apr 2022

Study says duplilumab reduces mortality from COVID-19

A recent report posted to the medRxiv* preprint server assessed the efficacy of dupilumab in blocking the IL-13 signaling pathway and its efficacy in reducing the COVID-19 associated mortality.

5 Apr 2022

Study provides key insights into the spread of Rocky Mountain spotted fever

Findings from a new study are providing important insights into the spread of Rocky Mountain spotted fever, which is transmitted from dogs to people through ticks. The new data are being used to create models that could help predict, and possibly prevent, future outbreaks.

5 Apr 2022

Swedish HCW study shows COVID booster shots have limited effect on Omicron

Researchers examine emerging infections in healthcare workers who received the booster vaccination either with or without prior SARS-CoV-2 infection.

5 Apr 2022

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Researchers evaluate the effectiveness of four COVID-19 vaccines against symptomatic infection, hospitalization, and death in convalescent individuals.

5 Apr 2022

Powerful testimonial videos address vaccine hesitancy among new and expectant mothers

The New York Vaccine Literacy Campaign at the CUNY Graduate School of Public Health and Health Policy has collaborated with Health Leads to produce a series of powerful testimonial videos featuring three new mothers sharing why they got the COVID-19 vaccine.

5 Apr 2022

UGA researchers track chatbot use for public health response activities during the pandemic

If you've been to a clinic for a vaccine or COVID test during the past two years, you've likely interacted with a chatbot. Chatbots are computer programs designed to simulate conversation with human users.

5 Apr 2022

Difficult experiences in childhood influence vaccine resistance in adulthood

Curious about why some people have been so passionately, often angrily, opposed to vaccination against the COVID-19 virus, a team of researchers with access to rare and unusual insights into the childhood forces that shape our adult lives thought they'd try to find out.

5 Apr 2022

SARS-CoV-2 Omicron breakthrough infections induce antibodies with cross-variant neutralization potential and recall memory B cells

Researchers reported breakthrough infections by SARS-CoV-2’s new variant of concern, Omicron, that elicited broadly cross-reactive neutralizing antibodies in the BNT162b2-vaccinated individuals.

5 Apr 2022

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

A new study analyzed the recall of pre-existent cross-reactive memory B cells upon the SARS-CoV-2 Omicron breakthrough infections.

5 Apr 2022

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Researchers assessed the cross-neutralization among three sublineages of the SARS-CoV-2 Omicron variant: BA.1, BA.2, and BA.3 sublineages, and an additional strain, USA/WA1-2020 (wild-type) in mice.

5 Apr 2022

Effectiveness of COVID-19 vaccines against hospitalization in those testing positive for Omicron and Delta variants

A recent study assessed the effectiveness of SARS-CoV-2 vaccines against the hospitalization of infected patients.

5 Apr 2022

Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

Researchers have focussed on detecting BA.1/BA.2 recombinant in travelers through surveillance.

5 Apr 2022

Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

Researchers performed a retrospective cohort study to identify predictors of mortality following hospitalization with influenza, respiratory syncytial virus, or SARS-CoV-2.

5 Apr 2022

Prior COVID vaccination induces a more robust antibody response to Omicron

A recent study posted to the medRxiv* preprint server assessed the impact of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination on the human immune response against SARS-CoV-2 Omicron infection.

5 Apr 2022

Study on the efficacy of a BNT162b2 booster dose in the elderly

In a recent study posted to the medRxiv* preprint server, researchers characterized the immune responses against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron variant after receiving a booster dose of BNT162b2 vaccine in older people.

5 Apr 2022

Pandemic to endemic: downside risks of widespread SARS-CoV-2 transmission

In a recent study posted to the medRxiv* preprint server, researchers evaluated the impact of changes in infection fatality rate (IFR), intrinsic reproductive number (R0), and the durability of immunity on the annual coronavirus disease 2019 (COVID-19) death toll in the United States (US). This study demonstrated the risks of abiding by the ‘live with the disease’ COVID-19 mitigation strategy.

4 Apr 2022

Vaccine News and Research

Latest Vaccine News and Research

How comorbidities impact antibody response to COVID vaccination

Study says duplilumab reduces mortality from COVID-19

Study provides key insights into the spread of Rocky Mountain spotted fever

Swedish HCW study shows COVID booster shots have limited effect on Omicron

Does COVID-19 vaccination benefit those with prior SARS-CoV-2 infection?

Powerful testimonial videos address vaccine hesitancy among new and expectant mothers

UGA researchers track chatbot use for public health response activities during the pandemic

Difficult experiences in childhood influence vaccine resistance in adulthood

SARS-CoV-2 Omicron breakthrough infections induce antibodies with cross-variant neutralization potential and recall memory B cells

Pre-existing memory B cell dynamics during SARS-CoV-2 Omicron breakthrough infection

Study demonstrates cross-neutralization among SARS-CoV-2 Omicron sublineages

Effectiveness of COVID-19 vaccines against hospitalization in those testing positive for Omicron and Delta variants

Study detects SARS-CoV-2 BA.1/BA.2 recombinant in two epidemiologically linked cases

Direction and magnitude of predictors of all-cause mortality following hospitalization with influenza, RSV, or SARS-CoV-2

Prior COVID vaccination induces a more robust antibody response to Omicron

Study on the efficacy of a BNT162b2 booster dose in the elderly

Pandemic to endemic: downside risks of widespread SARS-CoV-2 transmission

The SAVE initiative to monitor the impact of SARS-CoV-2 variants

BNT162b2 booster vaccine provides equal protection against BA.1 and BA.2

SARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in